Manitou Investment Management Ltd. Has $21.28 Million Stock Position in Danaher Co. (NYSE:DHR)

Manitou Investment Management Ltd. raised its holdings in Danaher Co. (NYSE:DHR) by 0.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 92,685 shares of the conglomerate’s stock after purchasing an additional 481 shares during the quarter. Danaher accounts for approximately 4.2% of Manitou Investment Management Ltd.’s investment portfolio, making the stock its 11th biggest position. Manitou Investment Management Ltd.’s holdings in Danaher were worth $21,276,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Hengehold Capital Management LLC boosted its stake in Danaher by 30.3% in the fourth quarter. Hengehold Capital Management LLC now owns 2,340 shares of the conglomerate’s stock valued at $537,000 after buying an additional 544 shares in the last quarter. True North Advisors LLC lifted its holdings in shares of Danaher by 70.8% in the fourth quarter. True North Advisors LLC now owns 1,720 shares of the conglomerate’s stock worth $395,000 after acquiring an additional 713 shares during the last quarter. Janney Montgomery Scott LLC boosted its stake in shares of Danaher by 1.7% in the 4th quarter. Janney Montgomery Scott LLC now owns 184,484 shares of the conglomerate’s stock valued at $42,349,000 after purchasing an additional 3,161 shares in the last quarter. Daymark Wealth Partners LLC grew its holdings in shares of Danaher by 0.9% during the 4th quarter. Daymark Wealth Partners LLC now owns 17,521 shares of the conglomerate’s stock valued at $4,022,000 after purchasing an additional 155 shares during the last quarter. Finally, Albion Financial Group UT lifted its stake in Danaher by 360.7% in the 4th quarter. Albion Financial Group UT now owns 1,290 shares of the conglomerate’s stock valued at $296,000 after purchasing an additional 1,010 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on DHR shares. Scotiabank started coverage on shares of Danaher in a research note on Monday, December 23rd. They set a “sector perform” rating and a $265.00 target price on the stock. Citigroup reduced their price objective on Danaher from $305.00 to $285.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Stifel Nicolaus increased their target price on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research report on Wednesday, October 23rd. UBS Group reduced their price target on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a report on Wednesday, October 23rd. Finally, TD Cowen raised their price objective on shares of Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and a consensus target price of $285.55.

Danaher Stock Performance

DHR stock opened at $245.73 on Friday. The firm has a market cap of $177.49 billion, a PE ratio of 46.90, a price-to-earnings-growth ratio of 4.43 and a beta of 0.83. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The stock has a 50-day moving average price of $234.90 and a 200-day moving average price of $253.47. Danaher Co. has a 1-year low of $225.42 and a 1-year high of $281.70.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same period in the previous year, the company posted $2.02 earnings per share. As a group, equities research analysts expect that Danaher Co. will post 7.5 earnings per share for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be paid a $0.27 dividend. The ex-dividend date is Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. Danaher’s dividend payout ratio is currently 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.